McCarter lawyers played a leading role the two In Re Accutane decisions highlighted by Law360 as among the “Top Product Liability Cases of 2018.” Partner Natalie Mantell was counsel of record and a member of Roche’s litigation team in In Re: Accutane, while partners Edward Fanning and David Kott co-authored amicus briefs in both Accutane cases. Mr. Fanning presented oral argument before the NJ Supreme Court in both cases, arguing in favor of the presumption that FDA-approved labels are adequate to warn of pharmaceutical side effects, and that New Jersey should adopt the Daubert factor-based approach for determining the admissibility of expert testimony.
Click to read the full article: “Top Product Liability Cases of 2018“